The Multiple Myeloma Channel on VJHemOnc is an independent medical education platform, supported with funding from BMS (Gold) and Legend Biotech (Bronze). Supporters have no influence on the production of content. The levels of sponsorship listed are reflective of the amount of funding given.
COMy 2022 | The importance of novel targets in myeloma
In this video, Paola Neri, MD, PhD, University of Calgary, Calgary, AB, Canada, discusses novel therapeutic targets in multiple myeloma, including BCMA, GPRC5D, and FcRH5. Dr Neri also comments on the great potential of these targets for novel therapies, and the importance of better understanding these targets to provide patients with improved therapeutic options. This interview took place at the 8th World Congress on Controversies in Multiple Myeloma (COMy) 2022, held in Paris, France.
